Apalla Z, Sidiropoulos T, Kampouropoulou E, Papageorgiou M, et al. Real-life, long-term data on efficacy, safety, response and discontinuation patterns of omalizumab in a Greek population with chronic spontaneous urticaria. Eur J Dermatol 2020;30:716-722.
PMID: 33258453